202 Matching Annotations
  1. Jun 2021
    1. BRCA2: pathogenic variants

      Lots of variants!!!

    2. BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan

      PMID:33067490

      Gene: BRCA2

    3. wo novel pathogenic mutations were identified in BRCA2 genes
  2. Jan 2021
    1. Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing

      PMID: 28790153

      Gene: MYH7

      HGNC:7577

    2. AJV

      CaseAJV: 17 years diagnosis, Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Father (index case) died awaiting cardiac transplant (carried both variants). Two possibly affected relatives.

      CasePresentingHPOs: HP:0001639, HP:0006536

      (Hypertrophic cardiomyopathy, Obstructive lung disease)

      HPOsFreeText: Maximum left ventricular hypertrophy at 17 mm, Sudden cardiac death event at 17 years, Maximal wall thickness at 22mm,

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant:NM_000257.3:c.1954A>G (p.Arg652Gly)

      ClinVarID:177626 https://www.ncbi.nlm.nih.gov/clinvar/variation/177626/

      gnomAD: Not in gnomAD

      Multiple Gene Variants:

      MYBPC3 Variant

      Variant: NM_000256.3:c.2980C>T (p.Leu994Phe)

      ClinVarID:180992 https://www.ncbi.nlm.nih.gov/clinvar/variation/180992/

      gnomAD: European (Non-Finnish) 1.624e-4, Overall 8.461e-5 https://gnomad.broadinstitute.org/variant/11-47355487-G-A

  3. Dec 2019
  4. Oct 2019
  5. Sep 2019
    1. allele id lookup result

    2. Seizures
    3. 22 mo
    4. variant id lookup result

    5. constipation
    6. hairy elbows
    7. strabismus
    8. joint laxity
    9. fetal fingerpads
    10. mild hypertelorism
    11. long eyelashes
    12. mild exophthalmos
    13. broad forehead
    14. triangular face
    15. aggressivity
    16. no eye contact,
    17. social interaction
    18. autistic
    19. yes
    20. severe
    21. no speech
    22. 122 cm (−2.7)
    23. Facial dysmorphisms
    24. sleeping difficulties
    25. Behavioral abnormalities
    26. developmental delay
    27. FBXO11
    1. GENE CURATION WORKFLOW

      This figure has been updated to reflect the current curation workflow and approval process.

    2. APPENDIX C:SEMIDOMINANT MODE OF INHERITANCE OVERVIEW

      New section that outlines examples on how to score Semidominant mode of inheritance in the GCI.

    3. PMID: 18853439

      Using these PMIDs allows a curator to score applicable evidence within the GCI that is included as part of a general, large resource database.

    4. APPENDIX A:

      This section was updated to include new useful websites, including PMIDs to use for curation purposes on websites that may house important evidence (e.g. The Human Protein Atlas, MGI, IMPC, etc). A new section entitled Case-Level databases was added to provide curators with information on well-known sites containing case-level genetic evidence that may be applicable to scoring for a given gene-disease relationship.

    5. SOP REFERENCES

      This section was updated to reflect new references

    6. RECURATION PROCEDURE

      New section that outlines the procedures for all GCEPs to follow for recuration of gene-disease relationships under their purview. A hyperlink to the full recuration document is included.

    7. Figure 10footnotes

      New section that outlines additional information to consider for the final classification summary.

    8. SUMMARY &FINAL MATRIX

      This section has been updated to reflect the current curation workflow using the GCI.

    9. General Considerations for Variant Evidence Scoring:

      Updated section that provides guidance and recommendations for upgrading and downgrading default variant scores based on several lines of evidence, including mode of inheritance, computational predictors, population frequency, disease mechanism, phenotype, and constraint metrics.

    10. Founder variants:

      New section that provides guidance and recommendations for scoring founder variants in a given gene-disease relationship.

    11. Recurrent variants:

      New section that provides examples, guidance and recommendations for the evaluation of recurrent variants, or variants that have been observed multiple times for a given gene-disease relationship.

    12. Figure 3. Genetic evidence matrix footnotes

      New section that outlines important information on the matrix including max points per variant type and category, and information on how to manually override a calculated gene-disease validity classification in the GCI (visual representation on Figure 4, p18).

    13. Scoring Genetic Evidence: Default and Range score per case

      New section that outlines the purpose of the default and range scores per case.

    14. EVIDENCE COLLECTION

      This section has been updated to include additional useful publication search engines.

    15. Mode of inheritance (MOI):

      New section that outlines the current “Mode of inheritance” (MOI) options available in the GCI and how they affect the ability to score and/or publish gene-disease validity classifications to the website. A new table visually outlines the MOIs and scoring, approving, and publishing capabilities (Table 1).

    16. ESTABLISHING THE GENE-DISEASE-MODE OF INHERITANCE

      This is a new section outlining the process of selecting a gene, disease, and mode of inheritance. Hyperlinks to supportive resources, such as the ClinGen Lumping and Splitting guidelines, GeneTracker, etc. are provided.

    17. NO KNOWN DISEASE RELATIONSHIP3

      The classification of “No reported Evidence” has been updated to “No known disease relationship” in order to align with the new terminology recommendation from the international Gene Curation Consortium (GenCC).

    18. OVERVIEW OF GENE CURATION

      This section has been updated to reflect our current curation workflow.

    19. Optional:

      Information on Hypothes.is and a hyperlink to the Hypothes.is Annotation SOP is now included. This web-based annotation tool is used by many GCEPs, and has been shown to significantly reduce curation time.

    1. Hypothes.is Gene Annotation SOP v1

      The Hypothes.is Gene Annotations SOP version 1 is located under the "Additional Supporting Materials Tab."

      This protocol outlines procedures for annotating and tagging applicable gene curation evidence and is structured to capture fields required for the ClinGen Gene curation Interface (GCI).

    2. Standard Operating Procedures

      To see Hypothes.is annotated notes on the SOP, click the hyperlink on the webpage titled "Gene-Disease Validity Standard Operating Procedures, Version 7"

  6. Aug 2019
    1. Hypothes.is Gene Annotation SOP v1

      The Hypothes.is Gene Annotations SOP version 1 is located under the "Additional Supporting Materials Tab."

      This protocol outlines procedures for annotating and tagging applicable gene curation evidence and is structured to capture fields required for the ClinGen Gene curation Interface (GCI).

    2. Standard Operating Procedures

      To see Hypothes.is annotated notes on the SOP, click the hyperlink on the webpage titled "Gene-Disease Validity Standard Operating Procedures, Version 7"

    1. Version 7

      ClinGen Gene-Disease Validity Standard operating Procedures Version 7 was released on August 12, 2019.

    2. Table of Contents

      The Table of Contents is now interactive and “clickable.” Clicking on a section title will take the reader to the section of interest.

    1. Gene-Disease Validity Standard Operating Procedures, Version 7

      Click the following link to see SOP version 7 updates using Hypothes.is annotation. These notes will be similar to the HIGHLIGHTED version of the SOPv7.

  7. May 2019
  8. Mar 2019
  9. Feb 2019
  10. Dec 2018
    1. HNF4A
  11. Nov 2018
    1. ClinVar variant ID lookup result: https://www.ncbi.nlm.nih.gov/clinvar/variation/427942/

    2. ClinVar variant ID lookup result: https://www.ncbi.nlm.nih.gov/clinvar/variation/427941/

    3. PLAA
  12. Aug 2018
    1. PPM1D
    1. EMC1
  13. Jul 2018
  14. Jun 2018